# FDA Inspection 779103 - AGC Biologics, Inc. - April 18, 2012

Source: https://www.keypedia.com/records/fda_inspections/agc-biologics-inc/6f32386e-9fbb-45d1-88bb-78c6c4318828
Source feed: FDA_Inspections

> FDA Inspection 779103 for AGC Biologics, Inc. on April 18, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 779103
- Company Name: AGC Biologics, Inc.
- Inspection Date: 2012-04-18
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1265749 - 2025-04-18](https://www.keypedia.com/records/fda_inspections/agc-biologics-inc/4b5c17f5-89e1-4c63-b2e1-24bd1241af59)
- [FDA Inspection 1265749 - 2025-04-18](https://www.keypedia.com/records/fda_inspections/agc-biologics-inc/775242ad-2e18-4239-b13a-437601702335)
- [FDA Inspection 1197098 - 2023-02-10](https://www.keypedia.com/records/fda_inspections/agc-biologics-inc/a215b082-8d02-46ce-9fcd-9a697cc9dea5)
- [FDA Inspection 1149254 - 2021-07-23](https://www.keypedia.com/records/fda_inspections/agc-biologics-inc/c64c9870-4b2a-41b0-8194-185591ff15f1)
- [FDA Inspection 1109813 - 2018-10-15](https://www.keypedia.com/records/fda_inspections/agc-biologics-inc/637ed58c-aa5a-437a-8630-16864734811d)

Company: https://www.keypedia.com/companies/agc-biologics-inc/9759f733-dd5f-4f2e-a516-f1b37fad39e2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d